4-Antibody AG, of Basel, Switzerland, added Donald Drakeman to its board.
7TM Pharma A/S, of Horsholm, Denmark, appointed Peter Chambre chairman.
Adenosine Therapeutics LLC, of Charlottesville, Va., elected Jonathan Sackier chairman and H. Jeffrey Leighton vice chairman.
Adimab Inc., of Lebanon, N.H., appointed Stan Fields, James Marks and Bruce Tidor to its scientific advisory board.
Advanced Cell Technology Inc., of Los Angeles, appointed Jonathan Dinsmore senior vice president of regulatory and clinical and named Ivan Wolkind senior vice president of finance, administration and chief accounting officer.
Alfacell Corp., of Somerset, N.J., appointed Lawrence Kenyon chief operating officer and board member.
Altus Pharmaceuticals Inc., of Cambridge, Mass., elected David Pendergast chairman.
Amira Pharmaceuticals, of San Diego, appointed Isabelle Raizon-Ounis vice president of development.
APT Pharmaceuticals, of Burlingame, Calif., appointed Charles Johnson chief medical officer and Amy Burroughs Nader head of commercial and business development.
AVEO Pharmaceuticals Inc., of Cambridge, Mass., appointed David Johnston chief financial officer.
Biomoda Inc., of Albuquerque, N.M., named Leo Gomez director of research.
BioSeek Inc., of Burlingame, Calif., named Michael Venuti CEO and board member.
BioTrove Inc., of Woburn, Mass., named Jeffrey Leathe chief financial officer.